切換：
- 簡略
- 詳細(MARC)
- ISBD
-
New discoveries in the behavioral neuroscience of attention-deficit hyperactivity disorder /
紀錄類型 ： 書目-語言資料,印刷品: 單行本
其他作者 ： Stanford, S. Clare.
出版者 ： Cham :Springer,2022.
面頁冊數 ： 1 online resource (503 pages)
附註 ： 2.3 Summary: Methylphenidate and the Catecholamine Systems
內容註 ： Intro -- Preface -- Contents -- ADHD in Children and Adults: Diagnosis and Prognosis -- 1 Introduction -- 2 Diagnosis -- 3 ADHD in Preschool Children -- 4 ADHD in School-Aged Children -- 5 ADHD in Adolescents -- 6 ADHD in Adults -- 7 Conclusion -- References -- Current Pharmacological Treatments for ADHD -- 1 Introduction -- 2 Medications for ADHD and Their Mechanism of Action -- 2.1 Stimulant Medications -- 2.1.1 Methylphenidate -- 2.1.2 Amphetamine -- 2.2 Nonstimulants -- 2.2.1 Atomoxetine -- 2.2.2 Guanfacine and Clonidine -- 3 Pharmacokinetics of ADHD Medications
內容註 ： 4 ADHD Medications and the Cognitive Neuroscience of ADHD -- 5 Efficacy and Tolerability: Comparison Between Medications -- 6 Effects of ADHD Medications on Other Outcomes and Comorbidities -- 7 Factors to Consider When Choosing Treatments -- 8 Conclusions -- References -- The Benefits and Limitations of Stimulants in Treating ADHD -- 1 Introduction -- 2 Stimulants Used to Treat ADHD -- 3 Political, Ethical, and Moral Issues Relating to the Use of Stimulants for the Treatment of ADHD -- 4 The Treatment of Subsyndromal ADHD and the Use of Stimulants as Cognitive Enhancers
內容註 ： 5 Comparative Efficacy Between Stimulants and Non-pharmacological Treatments for ADHD -- 6 Comparative Efficacy, Effectiveness, and Safety of Pharmacological Treatments for ADHD -- 6.1 Children and Adolescents -- 6.2 Adults -- 6.3 Comparisons Between Different Stimulant Formulations -- 7 Clinical Implications of These Findings -- 8 Monitoring Treatment Response and the Potential Benefits of Integrating Measurement-Based Care Approaches into Clinical Prac ... -- 9 Do Stimulants Work and Are They Safe Over the Long Term? -- 10 Considerations for Different Clinical Populations
內容註 ： 11 Summary and Conclusions -- References -- New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development -- 1 Introduction -- 2 Current Status of Drugs to Treat ADHD -- 3 Non-clinical and Clinical Pharmacology of Approved Drugs to Treat ADHD -- 3.1 Lisdexamfetamine -- 3.2 Viloxazine -- 3.3 Prodrugs for Methylphenidate -- 3.4 Comment (Summary/Overview) -- 4 Update on the Progress of R & D in the Search for New Drugs to Treat ADHD -- 4.1 Centanafadine -- 4.2 Mazindol -- 4.3 Dasotraline -- 4.4 Vortioxetine -- 4.5 Droxidopa -- 4.6 Baicalin -- 4.7 Summary
內容註 ： 5 Progress in the Pharmacological Management of ADHD -- 5.1 Efficacy in ADHD -- 5.2 Once-Daily Medication -- 5.3 Relapse on Withdrawal -- 5.4 Drug-Induced Side Effects -- 5.5 Abuse Liability -- 6 The Link Between ADHD and Binge-Eating Disorder -- 7 Concluding Remarks -- References -- Effects of Methylphenidate on the Dopamine Transporter and Beyond -- 1 Introduction -- 2 Methylphenidate and the Central Catecholamine Systems -- 2.1 Methylphenidate and the Catecholamine Transporters -- 2.2 Methylphenidate and Other Catecholamine Protein Targets
標題 ： Attention-deficit hyperactivity disorder. -
標題 ： Attention-deficit hyperactivity disorder in adults. -
標題 ： Clinical neuropsychology. -
標題 ： Neuropsychiatry. -
標題 ： Attention Deficit Disorder with Hyperactivity -
ISBN ： 9783031118029
ISBN ： 3031118022
LEADER 04616nam 2200445 a 4500
001 50380
003 NhCcYBP
005 20240327141241.4
006 m o d
007 cr un|---aucuu
008 220806s2022 sz o 000 0 eng d
020 $a9783031118029$q(electronic bk.)
020 $a3031118022$q(electronic bk.)
020 $z9783031118012$q(print)
020 $z3031118014
024 7 $a10.1007/978-3-031-11802-9$2doi
035 $aebs3348547
040 $aNhCcYBP$cNhCcYBP
041 $aeng
050 4$aRJ506.H9$bN48 2022
072 7$aPSAN$2bicssc
072 7$aMED057000$2bisacsh
072 7$aPSAN$2thema
082 04$a616.85/89$223/eng/20220815
245 00$aNew discoveries in the behavioral neuroscience of attention-deficit hyperactivity disorder /$cS Clare Stanford, Emma Sciberras, editors.
260 $aCham :$bSpringer,$c2022.
300 $a1 online resource (503 pages)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aCurrent Topics in Behavioral Neurosciences ;$vv. 57
500 $a2.3 Summary: Methylphenidate and the Catecholamine Systems
505 0 $aIntro -- Preface -- Contents -- ADHD in Children and Adults: Diagnosis and Prognosis -- 1 Introduction -- 2 Diagnosis -- 3 ADHD in Preschool Children -- 4 ADHD in School-Aged Children -- 5 ADHD in Adolescents -- 6 ADHD in Adults -- 7 Conclusion -- References -- Current Pharmacological Treatments for ADHD -- 1 Introduction -- 2 Medications for ADHD and Their Mechanism of Action -- 2.1 Stimulant Medications -- 2.1.1 Methylphenidate -- 2.1.2 Amphetamine -- 2.2 Nonstimulants -- 2.2.1 Atomoxetine -- 2.2.2 Guanfacine and Clonidine -- 3 Pharmacokinetics of ADHD Medications
505 8 $a4 ADHD Medications and the Cognitive Neuroscience of ADHD -- 5 Efficacy and Tolerability: Comparison Between Medications -- 6 Effects of ADHD Medications on Other Outcomes and Comorbidities -- 7 Factors to Consider When Choosing Treatments -- 8 Conclusions -- References -- The Benefits and Limitations of Stimulants in Treating ADHD -- 1 Introduction -- 2 Stimulants Used to Treat ADHD -- 3 Political, Ethical, and Moral Issues Relating to the Use of Stimulants for the Treatment of ADHD -- 4 The Treatment of Subsyndromal ADHD and the Use of Stimulants as Cognitive Enhancers
505 8 $a5 Comparative Efficacy Between Stimulants and Non-pharmacological Treatments for ADHD -- 6 Comparative Efficacy, Effectiveness, and Safety of Pharmacological Treatments for ADHD -- 6.1 Children and Adolescents -- 6.2 Adults -- 6.3 Comparisons Between Different Stimulant Formulations -- 7 Clinical Implications of These Findings -- 8 Monitoring Treatment Response and the Potential Benefits of Integrating Measurement-Based Care Approaches into Clinical Prac ... -- 9 Do Stimulants Work and Are They Safe Over the Long Term? -- 10 Considerations for Different Clinical Populations
505 8 $a11 Summary and Conclusions -- References -- New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development -- 1 Introduction -- 2 Current Status of Drugs to Treat ADHD -- 3 Non-clinical and Clinical Pharmacology of Approved Drugs to Treat ADHD -- 3.1 Lisdexamfetamine -- 3.2 Viloxazine -- 3.3 Prodrugs for Methylphenidate -- 3.4 Comment (Summary/Overview) -- 4 Update on the Progress of R & D in the Search for New Drugs to Treat ADHD -- 4.1 Centanafadine -- 4.2 Mazindol -- 4.3 Dasotraline -- 4.4 Vortioxetine -- 4.5 Droxidopa -- 4.6 Baicalin -- 4.7 Summary
505 8 $a5 Progress in the Pharmacological Management of ADHD -- 5.1 Efficacy in ADHD -- 5.2 Once-Daily Medication -- 5.3 Relapse on Withdrawal -- 5.4 Drug-Induced Side Effects -- 5.5 Abuse Liability -- 6 The Link Between ADHD and Binge-Eating Disorder -- 7 Concluding Remarks -- References -- Effects of Methylphenidate on the Dopamine Transporter and Beyond -- 1 Introduction -- 2 Methylphenidate and the Central Catecholamine Systems -- 2.1 Methylphenidate and the Catecholamine Transporters -- 2.2 Methylphenidate and Other Catecholamine Protein Targets
533 $aElectronic reproduction.$bIpswich, MA$nAvailable via World Wide Web.
588 0 $aOnline resource; title from PDF title page (SpringerLink, viewed August 15, 2022).
650 0$aAttention-deficit hyperactivity disorder.$369910
650 0$aAttention-deficit hyperactivity disorder in adults.$394035
650 0$aClinical neuropsychology.$340504
650 0$aNeuropsychiatry.$325560
650 2$aAttention Deficit Disorder with Hyperactivity$366399
700 1 $aStanford, S. Clare.$395112
700 1 $aSciberras, Emma.$395113
710 2 $aEBSCOhost$387894
776 08$iPrint version:$aStanford, S. Clare.$tNew Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder.$dCham : Springer International Publishing AG, �2022$z9783031118012
830 0$aCurrent topics in behavioral neurosciences ;$vv. 59.$x1866-3389$388921
856 40$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3348547$zClick to View (限總院院內)
New discoveries in the behavioral neuroscience of attention-deficit hyperactivity disorder /S Clare Stanford, Emma Sciberras, editors. - Cham :Springer,2022. - 1 online resource (503 pages) - Current Topics in Behavioral Neurosciences ;v. 57. - Current topics in behavioral neurosciences ;v. 59..
2.3 Summary: Methylphenidate and the Catecholamine Systems
Intro -- Preface -- Contents -- ADHD in Children and Adults: Diagnosis and Prognosis -- 1 Introduction -- 2 Diagnosis -- 3 ADHD in Preschool Children -- 4 ADHD in School-Aged Children -- 5 ADHD in Adolescents -- 6 ADHD in Adults -- 7 Conclusion -- References -- Current Pharmacological Treatments for ADHD -- 1 Introduction -- 2 Medications for ADHD and Their Mechanism of Action -- 2.1 Stimulant Medications -- 2.1.1 Methylphenidate -- 2.1.2 Amphetamine -- 2.2 Nonstimulants -- 2.2.1 Atomoxetine -- 2.2.2 Guanfacine and Clonidine -- 3 Pharmacokinetics of ADHD Medications
Electronic reproduction.
Ipswich, MA
Available via World Wide Web.
ISBN: 9783031118029
Standard No.: 10.1007/978-3-031-11802-9doiSubjects--Topical Terms:
69910
Attention-deficit hyperactivity disorder.
LC Class. No.: RJ506.H9 / N48 2022
Dewey Class. No.: 616.85/89
2.3 Summary: Methylphenidate and the Catecholamine Systems
Intro -- Preface -- Contents -- ADHD in Children and Adults: Diagnosis and Prognosis -- 1 Introduction -- 2 Diagnosis -- 3 ADHD in Preschool Children -- 4 ADHD in School-Aged Children -- 5 ADHD in Adolescents -- 6 ADHD in Adults -- 7 Conclusion -- References -- Current Pharmacological Treatments for ADHD -- 1 Introduction -- 2 Medications for ADHD and Their Mechanism of Action -- 2.1 Stimulant Medications -- 2.1.1 Methylphenidate -- 2.1.2 Amphetamine -- 2.2 Nonstimulants -- 2.2.1 Atomoxetine -- 2.2.2 Guanfacine and Clonidine -- 3 Pharmacokinetics of ADHD Medications
Electronic reproduction.
Ipswich, MA
Available via World Wide Web.
ISBN: 9783031118029
Standard No.: 10.1007/978-3-031-11802-9doiSubjects--Topical Terms:
69910
Attention-deficit hyperactivity disorder.
LC Class. No.: RJ506.H9 / N48 2022
Dewey Class. No.: 616.85/89
- 館藏(0)
- 心得(0)
- 標籤
- 相同喜好的讀者(0)
- 相關資料(0)
發表心得